相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1-2 study
Birgit Geoerger et al.
LANCET ONCOLOGY (2020)
Prospective use of the single-mouse experimental design for the evaluation of PLX038A
Samson Ghilu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2020)
Evaluation of Eribulin Combined with Irinotecan for Treatment of Pediatric Cancer Xenografts
Andrew J. Robles et al.
CLINICAL CANCER RESEARCH (2020)
Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial
Kara L. Davis et al.
LANCET ONCOLOGY (2020)
Route of 41BB/41BBL Costimulation Determines Effector Function of B7-H3-CAR.CD28ζ T Cells
Phuong Nguyen et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells
Hongwei Du et al.
CANCER CELL (2019)
An FDA oncology analysis of toxicities associated with PBD-containing antibody-drug conjugates
Haleh Saber et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2019)
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design
Jo Lynne Rokita et al.
CELL REPORTS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
Robbie G. Majzner et al.
CLINICAL CANCER RESEARCH (2019)
Re-evaluating sample sizes in preclinical testing of patient-derived xenografts
Eric Earley et al.
CANCER RESEARCH (2019)
Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice
Megan Lo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Strategies and challenges for the next generation of antibody drug conjugates
Alain Beck et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
ADVL1412: Initial results of a phase I/II study of nivolumab and ipilimumab in pediatric patients with relapsed/refractory solid tumors-A COG study.
Kara L. Davis et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Assessment of Programmed Death-Ligand 1 Expression and Tumor-Associated Immune Cells in Pediatric Cancer Tissues
Robbie G. Majzner et al.
CANCER (2017)
Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma
Kristopher R. Bosse et al.
CANCER CELL (2017)
Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function
Young-hee Lee et al.
CELL RESEARCH (2017)
Harnessing the Immunotherapy Revolution for the Treatment of Childhood Cancers
Robbie G. Majzner et al.
CANCER CELL (2017)
Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature
Steven Seaman et al.
CANCER CELL (2017)
Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy
Rebecca Gardner et al.
BLOOD (2016)
Antibody-drug conjugates-an emerging class of cancer treatment
Nikolaos Diamantis et al.
BRITISH JOURNAL OF CANCER (2016)
Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse Analysis
Brendan Murphy et al.
CANCER RESEARCH (2016)
B7-H3 Overexpression Predicts Poor Survival of Cancer Patients: A Meta-Analysis
Zhimeng Ye et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
New developments for antibody-drug conjugate-based therapeutic approaches
Bart E. C. G. de Goeij et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality
Rachelle G. Veenstra et al.
BLOOD (2015)
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W. Lee et al.
LANCET (2015)
Acute Lymphoblastic Leukemia in Children
Stephen P. Hunger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing neoplasms or neoplasms whose vasculature expresses B7-H3
John Powderly et al.
Journal for ImmunoTherapy of Cancer (2015)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Outcome for Children with Metastatic Solid Tumors over the Last Four Decades
Stephanie M. Perkins et al.
PLOS ONE (2014)
A Potent Anti-CD70 Antibody-Drug Conjugate Combining a Dimeric Pyrrolobenzodiazepine Drug with Site-Specific Conjugation Technology
Scott C. Jeffrey et al.
BIOCONJUGATE CHEMISTRY (2013)
B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma
Zhiping Zhou et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
B7-H3 is Overexpressed in Patients Suffering Osteosarcoma and Associated with Tumor Aggressiveness and Metastasis
Ling Wang et al.
PLOS ONE (2013)
Development of an Fc-Enhanced Anti-B7-H3 Monoclonal Antibody with Potent Antitumor Activity
Deryk Loo et al.
CLINICAL CANCER RESEARCH (2012)
B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes
Christina Tekle et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The development of pyrrolobenzodiazepines as antitumour agents
John A. Hartley
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma
Kim Kramer et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Chronic Disease in the Childhood Cancer Survivor Study Cohort: A Review of Published Findings
Lisa Diller et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Survivors of childhood cancer: Coming of age
Melissa M. Hudson
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2008)
Cell killing by antibody-drug conjugates
Yelena V. Kovtun et al.
CANCER LETTERS (2007)
The B7 family of immune-regulatory ligands
M Collins et al.
GENOME BIOLOGY (2005)
Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains
P Steinberger et al.
JOURNAL OF IMMUNOLOGY (2004)
Long-term complications following childhood and adolescent cancer: Foundations for providing risk-based health care for survivors
KC Oeffinger et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2004)
B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells
LQ Luo et al.
JOURNAL OF IMMUNOLOGY (2004)
B7-H3:: A costimulatory molecule for T cell activation and IFN-γ production
AI Chapoval et al.
NATURE IMMUNOLOGY (2001)
分享论文
